商品名：Fluothane
Inhalant anesthetic. Halothane is a multi-halogenated ethane. It is characterized by rapid induction and recovery, high potency, and few adverse effects. Like other inhalant anesthetics, the mechanism of action is uncertain. They produce generalized, reversible depression of the CNS. The inhalant anesthetics vary in their solubility in blood, their potency, and the rate of induction and recovery. Those with low blood/gas partition coefficients are associated with the most rapid rates of induction and recovery. Halothane has a vapor pressure of 243 mm Hg (at 20° C), a blood/gas partition coefficient of 2.3, and a fat/blood coefficient of 51. Because of high solubility in fat, its clearance from the body is slower than other agents.
Halothane, like other inhalant anesthetics, is used for general anesthesia in animals. It has a minimum alveolar concentration (MAC) value of 1.04%, 0.87%, and 0.88% in cats, dogs, and horses, respectively. However, it has been replaced by newer inhalant anesthetics (e.g., isoflurane) in many veterinary practices.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
確認手上精確產品、有效標籤、法域核准與實際供應狀態。 由具麻醉能力的獸醫依物種、個別病患、麻醉目的與完整風險評估制定計畫。 確認適用且校準的藥物專用汽化器、麻醉機、迴路、氣道、供氧、通氣、清除廢氣與急救設備。 安排受訓專責人員持續監測氧合、通氣、循環、節律、血壓、灌流、麻醉深度、體溫與恢復。 分別評估惡性高熱易感性、兒茶酚胺心律不整風險、患者生殖狀態與工作人員暴露。
DRUGAPI 劑量審查引用的獸醫官方標示（各標示只適用於其產品、物種與法域，不可互換）
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
renal